Zobrazeno 1 - 10
of 226
pro vyhledávání: '"JP Jouet"'
Autor:
Jean-Frederic Colombel, F Bauters, Stéphane Depil, Vincent Maunoury, Pierre Desreumaux, S Couignoux, Ibrahim Yakoub-Agha, JP Jouet
Publikováno v:
Endoscopy. 36
Autor:
C Preudhomme, N Henic, B Cazin, JL Laï, MF Bertheas, M Vanrumbeke, F Lemoine, JP Jouet, E Deconninck, B Nelken, A Cosson, P Fenaux
Publikováno v:
Leukemia. 11(2)
We sequentially performed cytogenetic analysis and RT-PCR analysis of BCR-ABL transcripts in 17 cases of Ph1-positive ALL who had achieved hematological complete remission (CR) with intensive chemotherapy (CT). Sixteen cases were studied prospectivel
Autor:
Belanger C, Esperou-Bourdeau H, Bordigoni P, Jp, Jouet, Souillet G, Noel Milpied, Troussard X, Kuentz M, Herve P, Reiffers J
Publikováno v:
Europe PubMed Central
Severe acute GVHD remains the main complication in unrelated donor BMT (UD-BMT). The previous encouraging reports on the use of anti-IL-2 receptor monoclonal Ab (33B31) for GVHD prophylaxis in genoidentical BMT led us to add this Ab to the standard G
Autor:
Michallet M, Corront B, Hollard D, Gratwohl A, Noel Milpied, Dauriac C, Brunet S, Soler J, Jp, Jouet, Esperou Bourdeau H
Publikováno v:
Europe PubMed Central
Allogeneic bone marrow transplantation (BMT) was performed in 17 patients with chronic lymphocytic leukemia (CLL): 15 resistant and two untreated forms. There were 12 males and five females with a mean age of 40 years (32-49). The conditioning regime
Autor:
Devergie A, Reiffers J, Jp, Vernant, Herve P, Guyotat D, Maraninchi D, Rio B, Michallet M, Jp, Jouet, Noel Milpied
Publikováno v:
Europe PubMed Central
Data on 281 patients with chronic myelogenous leukemia who received bone marrow transplants were analysed. The median follow-up time was 40 months; 170 patients were in first chronic phase, 14 were in second chronic phase, 73 were in accelerated phas
Autor:
Devergie A, Reiffers J, Jp, Vernant, Jy, Cahn, Guyotat D, Maraninchi D, Rio B, Michallet M, Jp, Jouet, Noel Milpied
Publikováno v:
Europe PubMed Central
Data on 281 patients with chronic myelogenous leukemia who received bone marrow transplants were analyzed. The median follow-up time was 48 months. One hundred and seventy patients were in 1st chronic phase, 111 were in more advanced disease. The ove
Autor:
N. Cheron, G Andreu, J.P. Laporte, M.P. Noel-Walter, Yazid Belkacemi, M Labopin, A. Najman, Lemonnier Mp, F. Bauters, Stachowiak J, P. Morel, L. Fouillard, JP Jouet, P. Fenaux, Norbert-Claude Gorin, P Zunic, F. Isnard, M Aoudjhane, L. Douay, Manuel Lopez, S. Lesage
Publikováno v:
Cancer/Radiothérapie. 1:510
Publikováno v:
La Revue de Médecine Interne. 18:s176
Autor:
Pigneux A, Devergie A, Pochitaloff M, Rio B, Archimbaud E, Jy, Cahn, Leblond V, Michallet M, Jp, Jouet, François Guilhot
Publikováno v:
Europe PubMed Central
Thirty three patients with Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML) in relapse after allogenic bone marrow transplantation (BMT) were treated with recombinant alpha-interferon (IFN). Ten patients received IFN for cyto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::228f17a5a8b5230c3bc107fa2f4251da
http://europepmc.org/abstract/med/7581075
http://europepmc.org/abstract/med/7581075
Autor:
Jl, Laï, Jp, Jouet, Zandecki M, Jb, Savary, Fenaux P, Lepelley P, Brigitte Nelken, Bauters F, Deminatti M
Publikováno v:
Europe PubMed Central
In a cytogenetic study of 54 patients with acute monoblastic leukaemias (AML5) two had a (9;11) (p21;q23) translocation. In addition to the clone, with t(9;11), both patients had a second clone with t(9;11) and trisomy 8. These two patients were aged
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::104787edb09649521a88088a1213d613
http://europepmc.org/abstract/med/3481440
http://europepmc.org/abstract/med/3481440